fenozan has been researched along with Malaria in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dutta, GP; Jefford, CW; Tripathi, R | 1 |
Jefford, CW; Peters, W; Robinson, BL; Rossier, JC | 1 |
Jefford, CW; Misra, D; Peters, W; Robinson, BL; Rossier, JC; Rossiter, JC | 1 |
Fleck, SL; Peters, W; Robinson, BL | 1 |
4 other study(ies) available for fenozan and Malaria
Article | Year |
---|---|
Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans) against the multidrug-resistant strain of Plasmodium yoelii nigeriensis (MDR) in vivo.
Topics: Administration, Oral; Animals; Antimalarials; Biological Assay; Drug Resistance, Multiple; Humans; Malaria; Mice; Peanut Oil; Phenylpropionates; Plant Oils; Plasmodium yoelii; Random Allocation; Structure-Activity Relationship; Treatment Outcome | 2006 |
The chemotherapy of rodent malaria. XLVIII. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 1: Studies leading to the development of novel cis-fused cyclopenteno derivatives.
Topics: Animals; Antimalarials; Cyclohexane Monoterpenes; Drug Evaluation, Preclinical; Drug Resistance; Female; Malaria; Mice; Monoterpenes; Naphthalenes; Oxyquinoline; Peroxides; Phenylpropionates; Plasmodium berghei; Terpenes | 1993 |
The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against d
Topics: Animals; Antimalarials; Drug Evaluation, Preclinical; Drug Resistance; Female; Malaria; Mice; Phenylpropionates; Plasmodium berghei; Plasmodium yoelii; Structure-Activity Relationship | 1993 |
The chemotherapy of rodent malaria. LIV. Combinations of 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites.
Topics: Aminoquinolines; Animals; Antimalarials; Chloroquine; Drug Antagonism; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Malaria; Mefloquine; Mice; Naphthyridines; Parasitemia; Phenanthrenes; Phenylpropionates; Plasmodium berghei; Plasmodium yoelii | 1997 |